Literature DB >> 16162605

Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis?

D M Shavelle.   

Abstract

Angiotensin converting enzyme (ACE) inhibitors may become an accepted form of treatment for aortic stenosis in the future.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16162605      PMCID： PMC1769118          DOI： 10.1136/hrt.2004.056614

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


  24 in total

1.  New insights into the progression of aortic stenosis: implications for secondary prevention.

Authors:  S Palta; A M Pai; K S Gill; R G Pai
Journal:  Circulation       Date:  2000-05-30       Impact factor: 29.690

2.  Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia.

Authors:  W B Strawn; M C Chappell; R H Dean; S Kivlighn; C M Ferrario
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

3.  Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.

Authors:  B Schieffer; E Schieffer; D Hilfiker-Kleiner; A Hilfiker; P T Kovanen; M Kaartinen; J Nussberger; W Harringer; H Drexler
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

4.  Evidence that macrophages in atherosclerotic lesions contain angiotensin II.

Authors:  D D Potter; C G Sobey; P K Tompkins; J D Rossen; D D Heistad
Journal:  Circulation       Date:  1998-08-25       Impact factor: 29.690

5.  Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).

Authors:  Anand Chockalingam; S Venkatesan; T Subramaniam; V Jagannathan; S Elangovan; R Alagesan; G Gnanavelu; Smrita Dorairajan; B P Krishna; V Chockalingam
Journal:  Am Heart J       Date:  2004-04       Impact factor: 4.749

6.  Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.

Authors:  Riccardo Candido; Karin A Jandeleit-Dahm; Zemin Cao; Stefan P Nesteroff; Wendy C Burns; Stephen M Twigg; Rodney J Dilley; Mark E Cooper; Terri J Allen
Journal:  Circulation       Date:  2002-07-09       Impact factor: 29.690

Review 7.  Is aortic stenosis a preventable disease?

Authors:  Kwan-Leung Chan
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

8.  Hemodynamic effects of the angiotensin-converting enzyme inhibitor, ramipril, in patients with mild to moderate aortic stenosis and preserved left ventricular function.

Authors:  Kevin D O'Brien; Xue-Qiao Zhao; David M Shavelle; Michael T Caulfield; Rebecca A Letterer; Samir R Kapadia; Jeffrey L Probstfield; Catherine M Otto
Journal:  J Investig Med       Date:  2004-04       Impact factor: 2.895

9.  Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma.

Authors:  Kevin D O'Brien; David M Shavelle; Michael T Caulfield; Thomas O McDonald; Katherine Olin-Lewis; Catherine M Otto; Jeffrey L Probstfield
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

10.  Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis.

Authors:  Riccardo Candido; Terri J Allen; Markus Lassila; Zemin Cao; Vicki Thallas; Mark E Cooper; Karin A Jandeleit-Dahm
Journal:  Circulation       Date:  2004-03-15       Impact factor: 29.690
View more
  2 in total

1.  Evaluation and management of aortic valve and root disease.

Authors:  John B de Graft-Johnson; Thomas G Gleason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12

Review 2.  Involvement of inflammatory responses in the early development of calcific aortic valve disease: lessons from statin therapy.

Authors:  Seung Hyun Lee; Jae-Hoon Choi
Journal:  Anim Cells Syst (Seoul)       Date:  2018-09-28       Impact factor: 1.815
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.